Dynamic changes of CSF sTREM2 in preclinical Alzheimer’s disease: the CABLE study

BACKGROUND: Loss of function of triggering receptor expressed on myeloid cell 2 (TREM2), a key receptor selectively expressed by microglia in the brain, contributes to the development of Alzheimer’s disease (AD). Whether TREM2 levels are pathologically altered during the preclinical phase, and wheth...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Neurodegener
Main Authors: Ma, Ling-Zhi, Tan, Lan, Bi, Yan-Lin, Shen, Xue-Ning, Xu, Wei, Ma, Ya-Hui, Li, Hong-Qi, Dong, Qiang, Yu, Jin-Tai
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7149923/
https://ncbi.nlm.nih.gov/pubmed/32276587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13024-020-00374-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados